Human Renal Glomerular Endothelial Cells (HRGEC) are a specialized microvascular cell type with functions in the regulation of glomerular ultrafiltration. They form the inner part of the filtration barrier and play roles in pathophysiological processes in the glomerulum. HRGEC constitutively produce bio-active molecules, which can be amplified by inflammatory and thrombotic molecules. Endothelial cell injury due to a severe glomerular lesion can inhibit angiogenesis and result in sclerosis at the injured site. HRGEC injury affects mesangial and epithelial cells and leads to the progression of renal disease. The biological properties of HRGEC remain largely unknown because of difficulties associated with the culturing, cloning and propagation of these cells. HRGEC in culture provide a useful in vitro model for studying the relationship between endothelal cells and renal disease. They are also useful tools to stablish in vitro disease models for High Throughput and High Content Screening.

Innoprot/人肾小球内皮细胞/P10665
市场价:
¥1680000.00
美元价:
840000.00
产品分类:
细胞转染
公司分类:
Cell_transfection
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
- Product Description
- Specifications
- Characterization
- Similars
- Publications
- Technical Resources & Protocols
- Reference: P10665
- Size/Quantity: 5x105 cells / vial
- Product Use: For research use only
- Shipping Conditions: Dry Ice
- Data Sheet - Cell Culture Manual
品牌介绍
Innoprot是一家生物技术公司,成立于2007年,是巴斯克地区大学的附属公司。Innoprot提供产品和技术,用于在药物发现和开发中对基于细胞的测定进行多路复用,包括原代细胞,永生细胞系和重组细胞系。凭借专有的GPCR筛选技术,Innoprot能够鉴定具有最高效力的化合物,同时避免了不良副作用。Innoprot还担任CRO,提供针对GPCR,纤维化和神经退行性疾病(例如阿尔茨海默氏病,帕金森氏病或ALS)的筛查服务。Inno prot的私人员工将药物发现技术领域的经验与制药服务提供商广泛的职业道路相结合。
联络我们